TEK and cutaneous mastocytosis: Furthermore, AKB-9778-mediated activation of Tie-2 could provide an additional benefit in combating CM pathogenesis as it has also been shown to block the binding of leukocytes to the vascular wall (Frye et al, 2015), with recent reports describing their accumulation in the brain vasculature of CM patients (Riggle et al, 2020).